Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 18, 1999

View Archived Issues

Scios signs drug screening and license agreement with Telik

Ares-Serono signs agreement with PowderJect for drug delivery system

Apotex extends agreement with Cangene

Preliminary results of testosterone replacement gel reported

Allelix clones GLP-2 receptor; advances development of ALX-0600

Preventive AIDS vaccine trial to begin in Thailand

Proteomics research grant awarded to Kinetek

New hemophilia treatment approved by Health Canada

Dainippon will initiate overseas trials of beta3 agonist

Yamanouchi, Ono establish codevelopment and marketing agreement for bisphosphonate

Zarix in-licenses oncology drug from Agouron

Another European market opens up to desirudin

Specific inhibitors of MEK for cancer and other proliferative disorders

New series of anticoagulants for oral administration developed at Lilly

More from SmithKline Beecham on p38 MAP kinase inhibitors

Patent covers new ADIR compounds with high affinity for imidazoline receptors

VUFB's phase III antirheumatic agent is available for licensing

Roche discloses inhibitors of TNF-alpha/TGF-alpha release, keratinocyte proliferation

First orally active, nonsteroidal androgen receptor agonist discovered at Ligand

CD-437, a novel retinoid compound targeted to the treatment of leukemia

Inhale branches out into pulmonary controlled release

AZT-cyclam/bicyclam prodrug conjugates designed at INSERM

Salix negotiates lafutidine license agreement with Fujirebio

FR-167653 compared to dexamethasone in acute lung inflammation

Wyeth-Ayerst seeks European approval of Rapamune

Amlodipine not associated with adverse arrhythmic events in CAD patients

CoCensys enters research agreements with Senju and Parke-Davis

Statins may be drugs of choice for adolescents with HeFH

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...